Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 6, 2005, Pages

  Fisher, Jonathan S ^a   Ju, Jeong Sun ^a   Oppelt, Peter J ^a   Smith, Jill L ^a   Suzuki, Atsushi ^b   Esumi, Hiroyasu ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Novel kinase family 1; Novel kinase family 2; Phosphotyrosine; Protein kinase B; Sucrose nonfermenting protein kinase AMP activated protein kinase related protein kinase

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PHOSPHOPROTEIN; PHOSPHOTYROSINE; PROTEIN ARK 5; PROTEIN KINASE B; UNCLASSIFIED DRUG; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; ANTIDIABETIC AGENT; ARK5 PROTEIN, RAT; DRUG DERIVATIVE; MESSENGER RNA; NUAK1 PROTEIN, HUMAN; PROTEIN KINASE; REPRESSOR PROTEIN; RIBONUCLEOTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ELECTROSTIMULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING; ANIMAL; BINDING SITE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; RAT; WISTAR RAT;

AMINO ACID SEQUENCE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; ENZYME ACTIVATION; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; IMMUNOSORBENT TECHNIQUES; INSULIN; MALE; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, WISTAR; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOTIDES; RNA, MESSENGER;

EID: 33644664089     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00335.2004     Document Type: Article

References (39)

1. Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, Stapleton D, and Kemp BE. Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci 13: 155-165, 2004.
2. Al Khalili L, Chibalin AV, Yu M, Sjodin B, Nylen C, Zierath JR, and Krook A. MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol 286: C1410-C1416, 2004.
3. Barnes BR, Ryder JW, Steiler TL, Fryer LG, Carling D, and Zierath JR. Isoform-specific regulation of 5′ AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes 51: 2703-2708, 2002.
4. Blom N, Gammeltoft S, and Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294: 1351-1362, 1999.
5. Brozinick JT Jr and Birnbaum MJ. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem 273: 14679-14682, 1998.
6. Cartee GD, Young DA, Sleeper MD, Zierath J, Wallberg-Henriksson H, and Holloszy JO. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol Endocrinol Metab 256: E494-E499, 1989.
7. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
8. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
9. Fisher JS, Gao J, Han DH, Holloszy JO, and Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282: E18-E23, 2002.
10. Garetto LP, Richter EA, Goodman MN, and Ruderman NB. Enhanced muscle glucose metabolism after exercise in the rat: the two phases. Am J Physiol Endocrinol Metab 246: E471-E475, 1984.
11. Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183, 2003.
12. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
13. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, and Kraegen EW. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulinresistant high-fat-fed rats. Diabetes 51: 2886-2894, 2002.
14. Kane S, Sano H, Liu SC, Asara JM, Lane WS, Garner CC, and Lienhard GE. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 277: 22115-22118, 2002.
15. Kaufmann S and Kellner U. Erasure of western blots after autoradiographic or chemiluminescent detection. Methods Mol Biol 80: 223-235, 1998.
16. Kazusa DNA. Research Institute (Japan). Gene/Protein Characteristic Table for KIAA0537. http://www.kazusa.or.jp/huge/gfpage/KIAA0537/ [2002].
17. Kida Y, Nyomba BL, Bogardus C, and Mott DM. Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans. J Clin Invest 87: 673-679, 1991.
18. Kim J, Solis RS, Arias EB, and Cartee GD. Post-contraction insulin sensitivity: relationship with contraction protocol, glycogen concentration, and 5′ AMP-activated protein kinase phosphorylation. J Appl Physiol 284: 575-583, 2004.
19. Lavin MF. An unlikely player joins the ATM signalling network. Nat Cell Biol 2: E215-E217, 2000.
20. Lefebvre DL, Bai Y, Shahmolky N, Sharma M, Poon R, Drucker DJ, and Rosen CF. Identification and characterization of a novel sucrose-nonfermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem J 355: 297-305, 2001.
21. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, and Alessi DR. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23: 833-843, 2004.
22. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
23. Mu J, Brozinick JT Jr, Valladares O, Bucan M, and Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
24. NCBI. Homo Sapiens Gene ARK5 Encoding KIAA0537 Gene Product. http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=34&c=Gene&l= ARK5, 2004.
25. Ojuka EO, Nolte LA, and Holloszy JO. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl Physiol 88: 1072-1075, 2000.
26. Pessin JE and Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106: 165-169, 2000.
27. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, and Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17: 1688-1699, 1998.
28. Richter EA, Garetto LP, Goodman MN, and Ruderman NB. Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest 69: 785-793, 1982.
29. Sakamoto K, Goransson O, Hardie DG, and Alessi DR. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin and AICAR. Am J Physiol Endocrinol Metab 287: E310-E317, 2004.
30. Sakamoto K, Hirshman MF, Aschenbach WG, and Goodyear LJ. Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277: 11910-11917, 2002.
31. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, and Esumi H. ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation. Oncogene 22: 6177-6182, 2003.
32. Suzuki A, Kusakai GI, Kishimoto A, Lu J, Ogura T, Lavin MF, and Esumi H. Identification of a novel protein kinase mediating Akt survival signaling to ATM. J Biol Chem 278: 48-53, 2003.
33. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, and Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 24: 3526-3535, 2004.
34. Wallberg-Henriksson H and Holloszy JO. Activation of glucose transport in diabetic muscle: responses to contraction and insulin. Am J Physiol Cell Physiol 249: C233-C237, 1985.
35. Winder WW and Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270: E299-E304, 1996.
36. Winder WW and Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277: E1-E10, 1999.
37. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, and Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88: 2219-2226, 2000.
38. Yang DQ and Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2: 893-898, 2000.
39. Yang DQ and He J. ATM protein kinase participates in GLUT4 translocation by insulin in L6 muscle cells. Diabetologia 46, Suppl 2: A40-A41, 2003.